GoldenGolden
Advanced Search
Serum Institute of India

Serum Institute of India

Serum Institute of India is a company that manufactures vaccines and other pharmaceutical products

Serum Institute of India is a company that manufactures vaccines and other pharmaceutical products. The company was founded in 1996 in Pune, Maharashtra, India.

Serum Institute of India claims to be the largest vaccine manufacturer by number of doses. They have produced and sold over 1.5 billion doses of vaccines around the world. The company has manufacture vaccines for Polio, Diphtheria, Tetanus, Perussis, Hib, BCG, r-Hepatitis B, Measles, Mumps, and Rubella diseases.

COVID-19

With the outbreak of COVID-19 (coronavirus), Serum Institute of India has claimed to have found a breakthrough in developing a vaccine for the contagion. Their virus-vaccine strain has reached animal clinical trial stages. They expect results from these trials within two months.

The company has partnered with a US-based biotech drug research company, Codagenix, to develop a vaccine to fight the coronavirus. The company claims it is the first vaccine to move from the laboratory to pre-clinical trial phase and they expect the product to be ready by 2022.

Timeline

June 21, 2021
Serum Institute produces over 100 million Covishield doses in June.
April 28, 2021
Serum Institute of India announces that it was reducing the price of its Covishield vaccine for state governments from Rs 400 to Rs 300 per dose as a "philanthropic gesture".

People

Name
Role
LinkedIn

Adar Poonawalla

CEO

Cyrus Poonawalla

Managing Director

Further reading

Title
Author
Link
Type
Date

About Serum Institute Of India Pvt. Ltd.

Web

Serum Institute of India | Manufacturer of Vaccines & immuno-biologicals - GMP Vaccine Manufacturer

Web

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Serum Institute of India

Adar Poonwalla

Pune, Maharashtra, India

Biotechnology, pharmaceuticals

News

Title
Author
Date
Publisher
Description
August 17, 2021
Moneycontrol
Serum Institute has acquired stake from former co-owners Kairus Dadachanji and Shapoor Mistry, Schott and Serum Institute of India said in a joint statement.
Press Trust of India
August 17, 2021
@bsindia
The joint venture is for pharmaceutical packaging
Livemint
August 17, 2021
mint
Serum Institute was already a customer of Schott Kaisha, using their vials, ampoules and syringes
August 16, 2021
The Times of India
As per the ICMR study, the mixing of two vaccines (covidshield and covaxin) is safe and provides better immunity.
Press Trust of India
August 13, 2021
@bsindia
Read more about Serum chairman Cyrus Poonawalla against using cocktail of Covid vaccines on Business Standard. Serum Institute of India (SII) chairman Dr Cyrus Poonawalla on Friday said he was not in favour of administering two different coronavirus vaccines for better efficacy.Poonawalla, whose firm makes the Covishield vaccine, was speaking to reporters
Press Trust of India
August 13, 2021
@bsindia
Chairman of vaccine maker Serum Institute of India (SII), Dr Cyrus Poonawalla, on Friday hailed the Modi government saying that red-tapism and licence raj have come down under its rule.
August 13, 2021
The Economic Times
If anything misfires, "Serum will say that the other vaccine as not good and they (other vaccine company) will blame us claiming there was an issue with our vaccine," he said.
Sohini Das
August 4, 2021
@bsindia
SII will conduct trials on those aged between two to 17 years
July 31, 2021
Moneycontrol
The Centre has urged states and UTs to conduct special COVID-19 vaccination sessions for the destitute, beggars and vagabonds who may not have access to self-registration and lack resources for vaccination.
Livemint
July 30, 2021
mint
The industry has been playing a responsible part in ensuring vaccination of workers and their families, but given the scale and urgency of the vaccination program, we can complement and supplement the efforts of the government
PTI
July 27, 2021
News18
The trials would cover 920 children, 460 each in the agegroup of 1217 and 211 across 10 sites.
July 17, 2021
mint
'However, despite being vaccinated, entry guidelines might vary from country to country, so do read up before you travel,' Poonawalla said on Twitter
July 15, 2021
Moneycontrol
Hospitals say people are preferring free jabs at government centres, and only those who need vaccination urgently or willing to pay approach them. Experts say the current vaccination speed of 3-4 million per day isn't enough for a full economic recovery.
Aubrey Allegretti and Amelia Hill
July 14, 2021
the Guardian
Some holidaymakers returning from Spanish islands will need to quarantine when change enforced
Sohini Das
July 13, 2021
@bsindia
RDIF says SII can make combination doses of Astra-Sputnik in future
Press Trust of India
July 13, 2021
@bsindia
Serum Institute of India (SII) will start production of Sputnik vaccine at the companys facilities in September, Russian Direct Investment Fund (RDIF) said on Tuesday
July 13, 2021
Moneycontrol
Coronavirus News LIVE Updates: This constitutes an overall recovery rate of 97.22 per cent, which is showing a sustained increasing trend. The weekly positivity rate also remained below 5 per cent and is currently at 2.32 per cent.
Livemint
July 10, 2021
mint
Recognition from the EU will help people avail the EU Digital Covid Certificate or 'Green Pass', with an aim to facilitate free movement during the Covid-19 pandemic
July 8, 2021
Hindustan Times
Two days before the cabinet reshuffle, Mansukh Manadviya visited the Pune facility of the Serum Institute of India and interacted with Adar Poonawalla. | Latest News India
Sonia Faleiro
July 5, 2021
MIT Technology Review
There's no single reason for India's catastrophic covid surge. Instead, it's the result of basic mistakes and callous technocratic failures.
SHOW MORE

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.